These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 27313263)
1. Clinical Management of an Increasing Threat: Outpatient Urinary Tract Infections Due to Multidrug-Resistant Uropathogens. Walker E; Lyman A; Gupta K; Mahoney MV; Snyder GM; Hirsch EB Clin Infect Dis; 2016 Oct; 63(7):960-5. PubMed ID: 27313263 [TBL] [Abstract][Full Text] [Related]
2. Antibiotic Resistance Among Uropathogenic Kot B Pol J Microbiol; 2019 Dec; 68(4):403-415. PubMed ID: 31880885 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors for trimethoprim-sulfamethoxazole-resistant Escherichia coli among women with acute uncomplicated urinary tract infection in a developing country. Gangcuangco LM; Alejandria M; Henson KE; Alfaraz L; Ata RM; Lopez M; Saniel M Int J Infect Dis; 2015 May; 34():55-60. PubMed ID: 25748571 [TBL] [Abstract][Full Text] [Related]
4. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients. Sanchez GV; Baird AM; Karlowsky JA; Master RN; Bordon JM J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776 [TBL] [Abstract][Full Text] [Related]
5. An update on the management of urinary tract infections in the era of antimicrobial resistance. Bader MS; Loeb M; Brooks AA Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137 [TBL] [Abstract][Full Text] [Related]
6. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea. Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617 [TBL] [Abstract][Full Text] [Related]
7. An evaluation of E. coli in urinary tract infection in emergency department at KAMC in Riyadh, Saudi Arabia: retrospective study. Alanazi MQ; Alqahtani FY; Aleanizy FS Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):3. PubMed ID: 29422058 [TBL] [Abstract][Full Text] [Related]
8. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance. Miller LG; Tang AW Mayo Clin Proc; 2004 Aug; 79(8):1048-53; quiz 1053-4. PubMed ID: 15301333 [TBL] [Abstract][Full Text] [Related]
9. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations]. Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility and emerging resistance determinants (blaCTX-M, rmtB, fosA3) in clinical isolates from urinary tract infections in the Bolivian Chaco. Bartoloni A; Sennati S; Di Maggio T; Mantella A; Riccobono E; Strohmeyer M; Revollo C; Villagran AL; Pallecchi L; Rossolini GM Int J Infect Dis; 2016 Feb; 43():1-6. PubMed ID: 26686940 [TBL] [Abstract][Full Text] [Related]
11. Management of urinary tract infections from multidrug-resistant organisms. Gupta K; Bhadelia N Infect Dis Clin North Am; 2014 Mar; 28(1):49-59. PubMed ID: 24484574 [TBL] [Abstract][Full Text] [Related]
12. Time trend of prevalence and susceptibility to nitrofurantoin of urinary MDR Escherichia coli from outpatients. Bruyndonckx R; Latour K; Atud GA; Dubovy P; Jaspers S; Hens N; Catry B; Goossens H; Coenen S J Antimicrob Chemother; 2019 Nov; 74(11):3264-3267. PubMed ID: 31377782 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of urinary tract infections in the outpatient setting: a review. Grigoryan L; Trautner BW; Gupta K JAMA; 2014 Oct 22-29; 312(16):1677-84. PubMed ID: 25335150 [TBL] [Abstract][Full Text] [Related]
14. Treatment of recurrent complicated urinary tract infections in children with vesicoureteral reflux. Wu TH; Huang FL; Fu LS; Chou CM; Chien YL; Huang CM; Lin CF; Chen PY J Microbiol Immunol Infect; 2016 Oct; 49(5):717-722. PubMed ID: 25442872 [TBL] [Abstract][Full Text] [Related]
15. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections. Talan DA; Naber KG; Palou J; Elkharrat D Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329 [TBL] [Abstract][Full Text] [Related]
16. Urinary Tract Infections Caused by Uropathogenic Zhou Y; Zhou Z; Zheng L; Gong Z; Li Y; Jin Y; Huang Y; Chi M Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445714 [TBL] [Abstract][Full Text] [Related]
17. Comparison of community-onset healthcare-associated and hospital-acquired urinary infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and antimicrobial activities. Saltoglu N; Karali R; Yemisen M; Ozaras R; Balkan II; Mete B; Tabak F; Mert A; Hondur N; Ozturk R Int J Clin Pract; 2015 Jul; 69(7):766-70. PubMed ID: 25683907 [TBL] [Abstract][Full Text] [Related]
18. Escherichia coli antimicrobial susceptibility profile and cumulative antibiogram to guide empirical treatment of uncomplicated urinary tract infections in women in the province of Québec, 2010-15. Delisle G; Quach C; Domingo MC; Boudreault AA; Gourdeau M; Bernatchez H; Lavallée C J Antimicrob Chemother; 2016 Dec; 71(12):3562-3567. PubMed ID: 27494927 [TBL] [Abstract][Full Text] [Related]